Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study ...

Is It Too Late to Consider Ventas After a 36% Rally in 2025?

If you are wondering whether Ventas is still a smart buy after its big run, or if the easy money has already been made, you ...

Oracle: OpenAI Is A Huge Wildcard

Oracle stock faces a 42% drop post-OpenAI deal amid capex surge and leverage risks. Read the latest analysis on the stock ...

Cowboys stunned by J.J. McCarthy, Vikings as playoff hopes are just about over after Week 15

ARLINGTON, Texas -- The Dallas Cowboys' defense served as a slump buster of sorts for Vikings quarterback J.J. McCarthy in a ...
Bored Panda on MSN

46 things basically everyone has done but probably won’t admit to

Ever turned down the music in your car so that you can park properly? Yep, me too. We like to present as functioning, mature ...